AstraZeneca Hopes Danicopan Interim Data Will Prove Sufficient For NDA Filing

 
• By Joseph Haas
  
Hemolysis
AstraZeneca thinks danicopan can provided added benefit for some PNH patients • Source: Shutterstock

More from Clinical Trials

More from R&D